e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Tuberculosis drug resistance
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Estimation of susceptibility of multy-drug resistant strains of
Mycobacterium tuberculosis
(MTB) to chlorine containing disinfectants in experiment
N. Eremeeva (Yekaterinburg, Russian Federation)
Source:
Annual Congress 2010 - Tuberculosis drug resistance
Session:
Tuberculosis drug resistance
Session type:
Thematic Poster Session
Number:
4981
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Eremeeva (Yekaterinburg, Russian Federation). Estimation of susceptibility of multy-drug resistant strains of
Mycobacterium tuberculosis
(MTB) to chlorine containing disinfectants in experiment. Eur Respir J 2010; 36: Suppl. 54, 4981
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Estimation of resistance of M.tuberculosis different genotypes to disinfectants
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019
Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017
Minimal inhibitory concentrations (MIC) of first line drugs in multidrug resistant strains of M. tuberculosis (MDR-TB)
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
In vitro
and
in vivo
activity of thiourea (ISO), a mycolic acid inhibitor, against multi drug resistant (MDR) strains of
Mycobacterium tuberculosis
(
M. tb
)
Source: Eur Respir J 2005; 26: Suppl. 49, 700s
Year: 2005
In vitro activity of triclosan ( TCN ) and thiolactomycin ( TLM ) against multi-drug-resistant ( MDR ) strains of mycobacterium tuberculosis ( M. tb )
Source: Eur Respir J 2004; 24: Suppl. 48, 722s
Year: 2004
Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021
Relationship between rpoB mutations and minimum inhibitory concentrations of rifampicin in multi drug resistant strains of mycobacterium tuberculosis
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
Amikacin (AMK) minimum inhibitory concentrations (MICs) and mutational resistance in patients with treatment-refractory nontuberculous mycobacteria (NTM) lung disease (LD) treated with liposomal amikacin for inhalation (LAI)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
In vitro
and
vivo
study of isoxyl, a mycolic acid inhibitor for intermittent chemotherapy of multi drug resistant (MDR) strains of
mycobacterium tuberculosis
(M.tb)
Source: Eur Respir J 2006; 28: Suppl. 50, 587s
Year: 2006
Changes in susceptibility to antibiotics staphylococcus aureus under effect of dissolved ozone
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009
Extensively drug – resistant tuberculosis: detection of a Gyr B mutant resistance
Source: Annual Congress 2008 - Difficult tuberculosis cases
Year: 2008
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Minimal inhibiting concentration of cationic surfactants against various genotypes of mycobacterium tuberculosis (MBT)
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains
Source: Eur Respir J 2015; 45: 285-287
Year: 2015
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains
Source: Eur Respir J 2015; 45: 287-289
Year: 2015
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant
mycobacterium tuberculosis
in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Drug resistance patterns in patients with multi-drug resistant tuberculosis (MDR – TB)
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Prevalence of relevant multi-drug resistant (MDR) pathogens in a bronchiectasis (BE) cohort.
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Method of evaluation of tuberculocidal effectiveness of disinfectants in clinical strains of Mycobacterium tuberculosis
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010
Exposure to sub-lethal levels of penicillin G and high osmotic potential leads to stable antibiotic resistance in
Staphylococcus aureus
Source: Eur Respir J 2002; 20: Suppl. 38, 421s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept